Navigation Links
Varian Medical Systems Establishes Radiotherapy Training Center and Clinical Help Desk in Tokyo, Japan
Date:1/11/2012

S
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,700 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit http://www.varian.com or follow us on Twitter.

 FOR INFORMATION CONTACT: United States

JapanMeryl Ginsberg, (650) 424-6444

Tsuneo Kobayashi, +81.3.4486.5040meryl.ginsberg@varian.com

tsuneo.kobayashi@varian.comNote to editors: photos available at the following URL: click here.

 


'/>"/>
SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
2. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
3. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
5. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
6. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
7. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
8. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
9. BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies
10. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
11. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... IRVING, Texas , March 30, 2015  Caris ... that found drugs targeting specific pathways may have potentially ... uterine cancer. The study results were highlighted today in ... Society of Gynecologic Oncology (SGO) 2015 Annual Meeting on ... This study is one of four presented ...
(Date:3/30/2015)... March 30, 2015 NiQ ... systems," announced the high level interface capabilities of ... infotainment systems. The partnership between CarePlus™ ... terminals; this allows patients to choose the most ... and acuity. The advanced functionality of CarePlus™ allows ...
(Date:3/30/2015)... March 30, 2015 DURECT Corporation (Nasdaq: ... initiated a multi-dose Phase 1 clinical trial of ... in DURECT,s Epigenomic Regulator Program.  DUR-928 is an ... have broad applicability in metabolic diseases such as ... (NASH).  It may also play an important role ...
Breaking Medicine Technology:Caris Life Sciences' Multiplatform Tumor Profiling Enhances Understanding of Molecular Drivers and Treatment Selection in Uterine Carcinomas 2Caris Life Sciences' Multiplatform Tumor Profiling Enhances Understanding of Molecular Drivers and Treatment Selection in Uterine Carcinomas 3Caris Life Sciences' Multiplatform Tumor Profiling Enhances Understanding of Molecular Drivers and Treatment Selection in Uterine Carcinomas 4NiQ Health Announces CarePlus(TM) Integration with ClinicAll 2DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 2DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 3DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 4
... NYSE: SNY ) announced today the first Phase ... efficacy and safety of lixisenatide, a once-daily GLP-1 receptor agonist, ... were presented at the European Association for the Study of ... "These results demonstrated lixisenatide as a once daily GLP-1 ...
... Signum Biosciences, Inc. was recently awarded two Small Business ... Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), ... development of novel G-protein coupled receptor (GPCR) modulating therapeutics ... Through the first SBIR grant, Signum will develop ...
Cached Medicine Technology:Investigational Compound Once-Daily Lixisenatide Demonstrated Significant Improvement in Glucose Control in Patients with Type 2 Diabetes 2Investigational Compound Once-Daily Lixisenatide Demonstrated Significant Improvement in Glucose Control in Patients with Type 2 Diabetes 3Investigational Compound Once-Daily Lixisenatide Demonstrated Significant Improvement in Glucose Control in Patients with Type 2 Diabetes 4Signum Biosciences Awarded Two Additional NIH Grants for Development of Topical Therapeutics 2
(Date:3/30/2015)... 30, 2015 The partners of Urgent ... grand opening of the Bella Diosa Laser Med Spa, ... finest in laser med spa treatments. , February marked ... and the partnership bridges the medical services provided by ... provided by Bella Diosa for both women and men. ...
(Date:3/30/2015)... New York, New York (PRWEB) March 30, 2015 ... has been filed in California Superior Court on ... a serious heart birth defect after his mother was ... pregnancy. According to the March 6th filing in Alameda ... to alleviate nausea and vomiting that she experienced in ...
(Date:3/30/2015)... York, NY (PRWEB) March 30, 2015 ... has compiled the most frequently asked questions to ... on the process of egg donation. , ... program in early February, the IVF clinic has ... Verda Tunçbilek, the reputable fertility center provides attentive reproductive ...
(Date:3/30/2015)... 30, 2015 “ iCareTech ” was featured ... takes a look at the latest and coolest technology products ... reporter and technology expert, conducted the review and shared with ... dedicated to the medical and health fields. , Wearable technology ... over the past couple of years. Well, at CES, NewsWatch ...
(Date:3/30/2015)... 2015 Healthy, radiant skin can be ... staff of pharmacists is specially trained and skilled in ... eczema and other conditions. , Most people are unaware ... and/or PCP to tackle most skin conditions and offer ... employed specialty-trained pharmacists who have experience in consulting with ...
Breaking Medicine News(10 mins):Health News:Yonkers Celebrates the Grand Opening of Bella Diosa 2Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 2Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 3Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 4Health News:Top Fertility Clinic in Cyprus Answers Key Questions on Egg Donation Process 2Health News:Top Fertility Clinic in Cyprus Answers Key Questions on Egg Donation Process 3Health News:Top Fertility Clinic in Cyprus Answers Key Questions on Egg Donation Process 4Health News:World’s First Medical Intelligent Band was Featured on NewsWatch Television on January 30, 2015 2Health News:MedX Pharmacy Offers Skin Care Tips 2
... the number of primary care physicians in medically underserved ... who often exhibit a strong sense of responsibility for ... new study by UCLA researchers and colleagues published in ... Public Health . Training these students ...
... By Steven Reinberg HealthDay Reporter , ... a booster shot of the vaccine that protects against ... The panel made the recommendation because the vaccine ... In 2007, the U.S. Centers for Disease Control ...
... By Steven Reinberg HealthDay Reporter , WEDNESDAY, Oct. ... the dangers associated with high blood pressure and many are ... known as hypertension, hasn,t changed in a decade, health officials ... the U.S. Centers for Disease Control and Prevention, 30 percent ...
... research published today, researchers uncover evolution in action in ... pancreatic tumours mean that not only is cancer genetically ... cancer spread within a patient has acquired distinct mutations. ... are ten different, but related, tumours. The complexity of ...
... Scientists are reporting development of a new approach for dealing ... simply mask odors like today,s room fresheners, but eliminates them ... from nanoparticles hundreds of times smaller than peach fuzz ... gold standard. A report on these next-generation odor-fighters appears in ...
... (HealthDay News) -- People who regularly eat whole grains rather ... fat linked to a higher risk for heart disease and ... visceral adipose tissue (VAT) -- the fat that surrounds the ... blood pressure, high cholesterol and insulin resistance, health risk factors ...
Cached Medicine News:Health News:Doctors' sense of mission, self-identity key in choice to work in underserved areas 2Health News:Teens Should Get Meningitis Booster Shot: CDC Panel 2Health News:Percentage of U.S. Adults With Hypertension Holds Steady at 30% 2Health News:Forces for cancer spread: Genomic instability and evolutionary selection 2Health News:Forces for cancer spread: Genomic instability and evolutionary selection 3Health News:Eating Whole Grains, Fewer Refined Grains, May Help Heart 2
... laser system with a wavelength of 1,064 nm. ... as well as red and blue vein irregularities. ... with darker skin types (1 to 6) and ... improvement of skin texture. The handpieces special design ...
... source consists of a welded titanium capsule ... four resin beads. The capsule body ... serve as x-ray markers to identify the ... are supplied non-sterile when shipped and must ...
... a Q-switched ruby laser system ... nm. High Performance Combined with ... combination of high performance and ... mode effectively destroys the (natural ...
A Powerful New Quantitative Immunoassay for Monitoring Bladder Cancer Patients. Useful in Monitoring Patients for,Disease Progression and Recurrence....
Medicine Products: